Your product is now available from Integrated DNA Technologies.
Many of the Swift products you have grown to love are now part of our new complete portfolio, xGen™ NGS. Through this new partnership we are pleased to offer you comprehensive next generation sequencing solutions.
xGen NGS—made for you.
Unsure of what products are available? Or, perhaps you’d like guidance on which products are compatible? If so, try our xGen NGS Solutions Builder Tool today.
Welcome to the IDT family!
Find Archer now at IDT!
All Archer information is now available on IDT’s website. You can view Archer assays alongside IDT’s xGen™ NGS portfolio to find the best next generation sequencing solution for your lab.
Confidently detect more with Archer NGS assay solutions for your solid tumor, blood cancer, immune profiling, and genetic disease research.
Our Scientific Applications Support team has assembled a list of frequently asked questions to help you find answers quickly. Filter using one or more categories to focus on specific topics, or use the search bar to perform a text search.
Search all FAQs:
Does IDT regularly perform in silico analysis of COVID variants?
The IDT SARS-CoV-2 primer and probe sets are for research use only (RUO). Therefore, such products are expressly not intended for diagnosis of SARS-CoV-2 infections and are not for use in diagnostic procedures. As a part of IDT's on-going efforts to align our products to the research needs of our customers, IDT regularly conducts in silico analysis of the variants listed within the GISAID database against the SARS-CoV-2 genome and assesses the predicted Tm. Currently, the reported mutations of the Omicron variant have been identified throughout the SARS-CoV-2 genome; RUO SARS-CoV-2 primers and probes offered by IDT target the nucleocapsid gene.